Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Kalpit Patel's Stock Ratings
B. Riley Securities Analyst
Kalpit Patel is an analyst at B. Riley Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
-5.77%
Smart Score
Overall Average Return Percentile
23rd
Number of Ratings
84
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11/25/2025 | PDSB | Buy Now | PDS Biotechnology | $0.94 | 220.2% | $5 → $3 | Maintains | Buy | Get Alert | |
| 11/18/2025 | ORIC | Buy Now | ORIC Pharmaceuticals | $9.26 | — | — | Initiates | → Peer Perform | Get Alert | |
| 11/18/2025 | CORT | Buy Now | Corcept Therapeutics | $87.30 | — | — | Initiates | → Peer Perform | Get Alert | |
| 11/18/2025 | JANX | Buy Now | Janux Therapeutics | $14.88 | — | — | Initiates | → Peer Perform | Get Alert | |
| 11/18/2025 | TNGX | Buy Now | Tango Therapeutics | $9.12 | — | — | Initiates | → Peer Perform | Get Alert | |
| 11/18/2025 | ACLX | Buy Now | Arcellx | $68.34 | — | — | Initiates | → Peer Perform | Get Alert | |
| 11/18/2025 | SMMT | Buy Now | Summit Therapeutics | $17.30 | — | — | Initiates | → Peer Perform | Get Alert | |
| 11/18/2025 | SRRK | Buy Now | Scholar Rock Holding | $45.24 | -7.16% | → $42 | Initiates | → Outperform | Get Alert | |
| 11/18/2025 | SLNO | Buy Now | Soleno Therapeutics | $49.95 | 50.15% | → $75 | Initiates | → Outperform | Get Alert | |
| 11/18/2025 | RVMD | Buy Now | Revolution Medicines | $77.51 | -3.24% | → $75 | Initiates | → Outperform | Get Alert | |
| 11/18/2025 | CELC | Buy Now | Celcuity | $102.18 | 7.65% | → $110 | Initiates | → Outperform | Get Alert | |
| 07/30/2025 | DERM | Buy Now | Journey Medical | $7.70 | 55.84% | $9 → $12 | Maintains | Buy | Get Alert | |
| 06/03/2025 | KYMR | Buy Now | Kymera Therapeutics | $85.68 | -29.97% | $38 → $60 | Upgrade | Neutral → Buy | Get Alert | |
| 05/12/2025 | KYMR | Buy Now | Kymera Therapeutics | $85.68 | -55.65% | $41 → $38 | Maintains | Neutral | Get Alert | |
| 05/02/2025 | BCYC | Buy Now | Bicycle Therapeutics | $7.40 | 89.19% | $17 → $14 | Maintains | Neutral | Get Alert | |
| 03/20/2025 | AVBP | Buy Now | ArriVent BioPharma | $23.58 | 56.91% | → $37 | Initiates | → Buy | Get Alert | |
| 03/05/2025 | RIGL | Buy Now | Rigel Pharmaceuticals | $40.97 | -41.42% | $20 → $24 | Maintains | Neutral | Get Alert | |
| 02/18/2025 | GERN | Buy Now | Geron | $1.32 | 165.15% | $5.5 → $3.5 | Maintains | Buy | Get Alert | |
| 01/31/2025 | VSTM | Buy Now | Verastem | $9.43 | -4.56% | $7 → $9 | Maintains | Buy | Get Alert | |
| 01/30/2025 | FHTX | Buy Now | Foghorn Therapeutics | $4.29 | 133.1% | → $10 | Initiates | → Buy | Get Alert | |
| 12/13/2024 | BCYC | Buy Now | Bicycle Therapeutics | $7.40 | 129.73% | $28 → $17 | Maintains | Neutral | Get Alert | |
| 12/10/2024 | RIGL | Buy Now | Rigel Pharmaceuticals | $40.97 | -51.18% | $27 → $20 | Maintains | Neutral | Get Alert | |
| 12/06/2024 | RIGL | Buy Now | Rigel Pharmaceuticals | $40.97 | -34.1% | $17 → $27 | Maintains | Neutral | Get Alert | |
| 11/25/2024 | PDSB | Buy Now | PDS Biotechnology | $0.94 | 647.14% | $9 → $7 | Maintains | Buy | Get Alert | |
| 11/01/2024 | KYMR | Buy Now | Kymera Therapeutics | $85.68 | -52.15% | $36 → $41 | Maintains | Neutral | Get Alert | |
| 10/14/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | $45 → $60 | Downgrade | Buy → Neutral | Get Alert | |
| 09/20/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $9.44 | 323.73% | $85 → $40 | Maintains | Buy | Get Alert | |
| 08/09/2024 | GERN | Buy Now | Geron | $1.32 | 316.67% | $5 → $5.5 | Maintains | Buy | Get Alert | |
| 08/07/2024 | BCYC | Buy Now | Bicycle Therapeutics | $7.40 | 278.38% | $33 → $28 | Downgrade | Buy → Neutral | Get Alert | |
| 08/05/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | $36 → $45 | Maintains | Buy | Get Alert | |
| 07/24/2024 | VSTM | Buy Now | Verastem | $9.43 | -25.77% | $21 → $7 | Maintains | Buy | Get Alert | |
| 07/09/2024 | KYMR | Buy Now | Kymera Therapeutics | $85.68 | -57.98% | $31 → $36 | Maintains | Neutral | Get Alert | |
| 06/26/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $9.44 | 800.42% | → $85 | Initiates | → Buy | Get Alert | |
| 06/18/2024 | OVID | Buy Now | Ovid Therapeutics | $1.55 | 93.52% | $9 → $3 | Maintains | Buy | Get Alert | |
| 06/12/2024 | PDSB | Buy Now | PDS Biotechnology | $0.94 | 860.61% | $11 → $9 | Maintains | Buy | Get Alert | |
| 06/11/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | $30 → $36 | Maintains | Buy | Get Alert | |
| 05/09/2024 | VRDN | Buy Now | Viridian Therapeutics | $33.03 | -39.45% | $25 → $20 | Downgrade | Buy → Neutral | Get Alert | |
| 04/30/2024 | OVID | Buy Now | Ovid Therapeutics | $1.55 | 480.57% | → $9 | Initiates | → Buy | Get Alert | |
| 03/28/2024 | PDSB | Buy Now | PDS Biotechnology | $0.94 | 1074.08% | $14 → $11 | Reiterates | Buy → Buy | Get Alert | |
| 03/21/2024 | VRDN | Buy Now | Viridian Therapeutics | $33.03 | -24.31% | $29 → $25 | Maintains | Buy | Get Alert | |
| 03/06/2024 | RIGL | Buy Now | Rigel Pharmaceuticals | $40.97 | -96.95% | $1.25 → $1.25 | Maintains | Neutral | Get Alert | |
| 12/12/2023 | XFOR | Buy Now | X4 Pharmaceuticals | $3.76 | -73.4% | $3 → $1 | Downgrade | Buy → Neutral | Get Alert | |
| 10/09/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | $65 → $60 | Downgrade | Buy → Neutral | Get Alert | |
| 09/29/2023 | VSTM | Buy Now | Verastem | $9.43 | 122.69% | $21 → $21 | Reiterates | Buy → Buy | Get Alert | |
| 09/27/2023 | VSTM | Buy Now | Verastem | $9.43 | 122.69% | → $21 | Initiates | → Buy | Get Alert | |
| 09/12/2023 | BCYC | Buy Now | Bicycle Therapeutics | $7.40 | 345.95% | → $33 | Upgrade | Neutral → Buy | Get Alert | |
| 09/11/2023 | BCYC | Buy Now | Bicycle Therapeutics | $7.40 | 345.95% | $33 → $33 | Upgrade | Neutral → Buy | Get Alert | |
| 09/07/2023 | DERM | Buy Now | Journey Medical | $7.70 | -22.08% | → $6 | Reiterates | Buy → Buy | Get Alert | |
| 08/09/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | → $45 | Upgrade | Neutral → Buy | Get Alert | |
| 07/25/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.82 | 72.9% | $34 → $36 | Maintains | Buy | Get Alert | |
| 07/24/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | $51 → $45 | Maintains | Neutral | Get Alert | |
| 07/12/2023 | DERM | Buy Now | Journey Medical | $7.70 | -22.08% | $3 → $6 | Maintains | Buy | Get Alert | |
| 05/23/2023 | DERM | Buy Now | Journey Medical | $7.70 | -61.04% | $6 → $3 | Maintains | Buy | Get Alert | |
| 04/27/2023 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | → $13 | Initiates | → Buy | Get Alert | |
| 03/30/2023 | DERM | Buy Now | Journey Medical | $7.70 | -22.08% | → $6 | Reiterates | → Buy | Get Alert | |
| 03/29/2023 | PDSB | Buy Now | PDS Biotechnology | $0.94 | 1180.82% | → $12 | Reiterates | → Buy | Get Alert | |
| 03/20/2023 | GERN | Buy Now | Geron | $1.32 | 278.79% | → $5 | Reiterates | → Buy | Get Alert | |
| 01/23/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | $52 → $56 | Maintains | Neutral | Get Alert | |
| 11/16/2022 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | $3 → $1.5 | Downgrade | Buy → Neutral | Get Alert | |
| 11/11/2022 | INAB | Buy Now | IN8bio | $1.60 | 87.13% | $9 → $3 | Downgrade | Buy → Neutral | Get Alert | |
| 11/01/2022 | PDSB | Buy Now | PDS Biotechnology | $0.94 | 967.35% | → $10 | Initiates | → Buy | Get Alert | |
| 10/28/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | → $72 | Initiates | → Neutral | Get Alert | |
| 09/22/2022 | ALLO | Buy Now | Allogene Therapeutics | $1.53 | 1073.25% | $21 → $18 | Maintains | Buy | Get Alert | |
| 07/28/2022 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.82 | 48.88% | → $31 | Reinstates | → Buy | Get Alert | |
| 07/28/2022 | GERN | Buy Now | Geron | $1.32 | 203.03% | → $4 | Reinstates | → Buy | Get Alert | |
| 07/19/2022 | ENTX | Buy Now | Entera Bio | $2.23 | 124.22% | $6 → $5 | Maintains | Buy | Get Alert | |
| 06/23/2022 | VRDN | Buy Now | Viridian Therapeutics | $33.03 | -24.31% | → $25 | Initiates | → Buy | Get Alert | |
| 06/09/2022 | RIGL | Buy Now | Rigel Pharmaceuticals | $40.97 | -96.95% | $4 → $1.25 | Maintains | Neutral | Get Alert | |
| 06/07/2022 | VINC | Buy Now | Vincerx Pharma | $0.01 | 47900% | $12 → $6 | Maintains | Buy | Get Alert | |
| 04/13/2022 | BCYC | Buy Now | Bicycle Therapeutics | $7.40 | 345.95% | $62 → $33 | Downgrade | Buy → Neutral | Get Alert | |
| 03/23/2022 | RIGL | Buy Now | Rigel Pharmaceuticals | $40.97 | -90.24% | → $4 | Initiates | → Neutral | Get Alert | |
| 01/24/2022 | INAB | Buy Now | IN8bio | $1.60 | 461.38% | $19 → $9 | Maintains | Buy | Get Alert | |
| 01/24/2022 | INKT | Buy Now | MiNK Therapeutics | $12.66 | -21.01% | $24 → $10 | Maintains | Buy | Get Alert | |
| 01/24/2022 | MGTA | Buy Now | Magenta Therapeutics | — | — | $13 → $6 | Maintains | Buy | Get Alert | |
| 12/07/2021 | DERM | Buy Now | Journey Medical | $7.70 | 81.82% | → $14 | Initiates | → Buy | Get Alert | |
| 09/30/2021 | KYMR | Buy Now | Kymera Therapeutics | $85.68 | -21.8% | → $67 | Initiates | → Neutral | Get Alert | |
| 09/30/2021 | BCYC | Buy Now | Bicycle Therapeutics | $7.40 | 656.76% | → $56 | Initiates | → Buy | Get Alert | |
| 09/03/2021 | FBRX | Buy Now | Forte Biosciences | $21.18 | -85.84% | → $3 | Downgrade | Buy → Neutral | Get Alert | |
| 08/25/2021 | VINC | Buy Now | Vincerx Pharma | $0.01 | 207900% | → $26 | Initiates | → Buy | Get Alert | |
| 08/23/2021 | INAB | Buy Now | IN8bio | $1.60 | 1085.13% | → $19 | Initiates | → Buy | Get Alert | |
| 06/16/2021 | ENTX | Buy Now | Entera Bio | $2.23 | 303.59% | → $9 | Initiates | → Buy | Get Alert | |
| 05/18/2021 | MGTA | Buy Now | Magenta Therapeutics | — | — | → $21 | Initiates | → Buy | Get Alert | |
| 05/14/2021 | ALLO | Buy Now | Allogene Therapeutics | $1.53 | 3289.39% | → $52 | Initiates | → Buy | Get Alert | |
| 05/14/2021 | FBRX | Buy Now | Forte Biosciences | $21.18 | 244.66% | → $73 | Initiates | → Buy | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved